Thy1.2-PFN1C71G/Prp-PFN1C71G transgenic mice ("pt" or "pt(h)") express a C71G mutant human profilin 1 protein (with N-terminal V5 tag) predominantly in motor neurons and in both neurons and non-neuronal cells of the CNS. These mice exhibit motor neuron degeneration and abnormalities in cytoskeleton, proteasome, autophagy and stress granules. This is a model for studying the pathogenic role of PFN1 in familial amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease).
Zuoshang Xu, University of Massachusetts Medical School
Genetic Background | Generation |
---|---|
N2+pN2F10
|
Allele Type |
---|
Transgenic (Inserted expressed sequence, Humanized sequence) |
Allele Type |
---|
Transgenic (Inserted expressed sequence, Humanized sequence) |
Starting at:
$278.00 Domestic price for female 4-week |
556.00 Domestic price for breeder pair |
These mice harbor two transgenes, Prp-PFN1C71G and Thy1.2-PFN1C71G, each expressing a C71G mutant human profilin 1 protein with N-terminal V5 tag (V5-PFN1C71G) under direction of the mouse prion protein promoter or the human Thy1.2 promoter.
The Prp-PFN1C71G transgene has V5-PFN1C71G expression predominantly in the CNS (in both neurons and non-neuronal cells), with very low expression in the periphery. Specifically, expression is highest in the spinal cord, brainstem and forebrain, lower levels in cerebellum and kidney, and at undetectable levels in other organs.
The Thy1.2-PFN1C71G transgene drives V5-PFN1C71G expression predominantly in motor neurons. Specifically, expression is highest in the spinal cord and brainstem, followed by the forebrain. Little if any is expressed in the cerebellum and the peripheral organs.
When hemizygous for both transgenes, they are referred to as Thy1.2-PFN1C71G/Prp-PFN1C71G double transgenic mice (and were previously called "pt" mice).
When homozygous for Thy1.2-PFN1C71G and hemizygous for Prp-PFN1C71G are referred to as
Thy1.2-PFN1C71G/C71G/Prp-PFN1C71G triple transgenic mice (and were previously called "pt(h)" mice).
Furthermore, mice harboring only the Thy1.2-PFN1C71G transgene are referred to as Thy1.2-PFN1C71G (previously called "t") when hemizygous, and Thy1.2-PFN1C71G/C71G (previously called "t(h)") when homozygous.
Similarly, mice harboring only the Prp-PFN1C71G transgene are referred to as Prp-PFN1C71G (previously called "p") when hemizygous, and Prp-PFN1C71G/C71G (previously called "p(h)") when homozygous.
In order of most-to-least motor neuron disease severity: "pt(h)" : "t(h)" : "pt" : "t" : "p".
The "pt(h)" and "t(h)" mice have similar disease onset age (~125d), but "pt(h)" mice develop paralysis faster than "t(h)" mice (~60d after onset compared to ~170d after onset). While "t(h)" and "pt" mice have similar overall life expectancy (~250-350d), the "pt" mice have a much later disease onset (~250d) with rapid development of paralysis (~10d after onset).
The "pt(h)" genotype is most severely affected, with mice exhibiting motor neuron degeneration and abnormalities in cytoskeleton, proteasome, autophagy and stress granules.
Specifically, beginning at 3-4 months of age, "pt(h)" exhibit progressive loss of motor capabilities, with progressive loss of motor and sensory axons. Cytoskeleton defects in motor neurons include mutant PFN1 aggregation and reduced neurofilament L expression.
Alterations in autophagy pathway are evident throughout spinal cord, particularly in motor neurons.
At the paralysis disease stage (end stage), there is significant microgliosis, astrogliosis, motor neuron loss, elevated ubiquitin levels in the spinal cord, increased stress granules in the spinal motor neurons
Both "pt" and "pt(h)" mice are viable and fertile. The donating investigator reports that "pt(h)" mice breed normally, and they maintain their double transgenic colony by breeding "t(h)" females with "pt(h)" males.
Mice singly hemizygous for the Prp-PFN1C71G transgene ("p") express V5-PFN1C71G in both neurons and glia, but the expression levels are low. The "p" genotype does not manifest motor neuron degeneration symptoms during their lifespan. The donating investigator also reports they were not able to obtain homozygous Prp-PFN1C71G animals ("p(h)").
These mice harbor two transgenes, Prp-PFN1C71G and Thy1.2-PFN1C71G, each designed by Drs. Zuoshang Xu and John E. Landers (University of Massachusetts Medical School). The PFN1C71G protein (V5-PFN1C71G) encoded by each transgene is a human profilin 1 cDNA sequence (PFN1; 423 bp / 141 aa) harboring the C71G mutation associated with amyotrophic lateral sclerosis (ALS), with a V5-tag (45 bp) fused to its N-terminus.
The Prp-PFN1C71G transgene has the V5-PFN1C71G sequence inserted between exon 2 and exon 3 of mouse prion protein (PrP or Prnp) gene at a unique XhoI site in the MoPrP.Xho plasmid vector. The resulting 11,855 bp Prp-V5-PFN1 construct was microinjected into FVB/NJ embryos. Transgenic founder male 22 was bred with FVB/NJ females for germline transmission, and founder line 22 was found to have expression predominantly in the CNS. The integration site(s) and copy number of the Prp-PFN1C71G transgene is not known to date (February 2016). The Prp-PFN1C71G line 22 colony was maintained by breeding hemizygotes with FVB/NJ mice for at least one more generation, prior to using as below.
The Thy1.2-PFN1C71G transgene has the V5-PFN1C71G sequence inserted downstream of the modified ~6.5 kbp mouse Thy1.2 promoter sequences (Thy1; thymus cell antigen 1, theta). The resulting 1,171 bp Thy1-V5-PFN1 construct was microinjected into FVB/NJ embryos. Transgenic founder female 67 was bred with FVB/NJ males for germline transmission, and founder line 67 was found to have expression predominantly in the CNS. The integration site(s) and copy number of the Thy1.2-PFN1C71G transgene is not known to date (February 2016). The Thy1.2-PFN1C71G line 67 colony was maintained by breeding hemizygotes with FVB/NJ mice for at least one more generation, prior to using as below.
To generate the Prp-PFN1C71G Thy1.2-PFN1C71G mice, the two individual mouse lines were bred together. The donating investigator then maintained the colony by breeding females homozygous for Thy1.2-PFN1C71G ("t(h)" females) with males hemizygous for PrP-PFN1C71G and homozygous for Thy1.2-PFN1C71G ("pt(h)" males). In 2016, albino males harboring both transgenes were sent to The Jackson Laboratory Repository. Upon arrival, sperm was cryopreserved. To generate our live colony, an aliquot of the frozen sperm was used to fertilize oocytes from FVB/NJ mice (Stock No. 001800).
Expressed Gene | PFN1, profilin 1, human |
---|---|
Site of Expression | |
Expressed Gene | PFN1, profilin 1, human |
Site of Expression |
Allele Name | transgene insertion 22, Zuoshang Xu |
---|---|
Allele Type | Transgenic (Inserted expressed sequence, Humanized sequence) |
Allele Synonym(s) | Prp-PFN1C71G |
Gene Symbol and Name | Tg(Prnp-PFN1*C71G)22Zxu, transgene insertion 22, Zuoshang Xu |
Gene Synonym(s) | |
Promoter | Prnp, prion protein, mouse, laboratory |
Expressed Gene | PFN1, profilin 1, human |
Strain of Origin | FVB/N |
Chromosome | UN |
Molecular Note | The transgenic construct contains a mutant human profilin 1 cDNA sequence with a V5 tag (45 bp) fused to the N-terminus and inserted between exon 2 and exon 3 of mouse prion protein gene at a unique XhoI site in the MoPrP.Xho plasmid vector. PFN1 harbors the C71G mutation associated with amyotrophic lateral sclerosis (ALS). |
Allele Name | transgene insertion 67, Zuoshang Xu |
---|---|
Allele Type | Transgenic (Inserted expressed sequence, Humanized sequence) |
Allele Synonym(s) | Thy1.2-PFN1C71G |
Gene Symbol and Name | Tg(Thy1-PFN1*C71G)67Zxu, transgene insertion 67, Zuoshang Xu |
Gene Synonym(s) | |
Promoter | Thy1, thymus cell antigen 1, theta, mouse, laboratory |
Expressed Gene | PFN1, profilin 1, human |
Strain of Origin | Not Specified |
Chromosome | UN |
Molecular Note | The transgenic construct contains a mutant human profilin 1 cDNA sequence with a V5 tag (45 bp) fused to the N-terminus and inserted downstream of the modified ~6.5 kbp mouse Thy1.2 promoter sequences. PFN1 harbors the C71G mutation associated with amyotrophic lateral sclerosis (ALS). |
Prp-PFN1C71G transgenic mice were referred to as "p" or "p(h)" when hemizygous or homozygous, respectively.
Similarly, Thy1.2-PFN1C71G transgenic mice were referred to as "t" or "t(h)" when hemizygous or homozygous, respectively.
When hemizygous for both transgenes, they are referred to as Thy1.2-PFN1C71G/Prp-PFN1C71G double transgenic mice (and were previously called "pt" mice).
When homozygous for Thy1.2-PFN1C71G and hemizygous for Prp-PFN1C71G are referred to as Thy1.2-PFN1C71G/C71G/Prp-PFN1C71G triple transgenic mice (and were previously called "pt(h)" mice).
The donating investigator reports that "pt(h)" mice breed normally. They also report that breeding "t(h)" females with "pt(h)" males results in 50% "t(h)" offspring and 50% "pt(h)" offspring.
When maintaining our live colony at The Jackson Laboratory Repository, we will breed mice wildtype (noncarrier) for Prp-PFN1C71G and hemizygous for Thy1.2-PFN1C71G with mice hemizygous for Prp-PFN1C71G and homozygous for Thy1.2-PFN1C71G. That is, we will breed "t" mice with "pt(h)" mice.
When using the Thy1.2-PFN1C71G/C71G/Prp-PFN1C71G triple transgenic [or pt(h)] , Thy1.2-PFN1C71G/Prp-PFN1C71G double transgenic [or pt] mouse strain in a publication, please cite the originating article(s) and include JAX stock #028608 in your Materials and Methods section.
Service/Product | Description | Price |
---|---|---|
Hemizygous for Tg(Prnp-PFN1*C71G)22Zxu Hemizygous for Tg(Thy1-PFN1*C71G)67Zxu or Hemizygous for Tg(Prnp-PFN1*C71G)22Zxu non carrier for Tg(Thy1-PFN1*C71G)67Zxu |
Frozen Mouse Embryo | FVB/N-Tg(Prnp-PFN1*C71G)22Zxu Tg(Thy1-PFN1*C71G)67Zxu/J | $2595.00 |
Frozen Mouse Embryo | FVB/N-Tg(Prnp-PFN1*C71G)22Zxu Tg(Thy1-PFN1*C71G)67Zxu/J | $2595.00 |
Frozen Mouse Embryo | FVB/N-Tg(Prnp-PFN1*C71G)22Zxu Tg(Thy1-PFN1*C71G)67Zxu/J | $3373.50 |
Frozen Mouse Embryo | FVB/N-Tg(Prnp-PFN1*C71G)22Zxu Tg(Thy1-PFN1*C71G)67Zxu/J | $3373.50 |
Terms are granted by individual review and stated on the customer invoice(s) and account statement. These transactions are payable in U.S. currency within the granted terms. Payment for services, products, shipping containers, and shipping costs that are rendered are expected within the payment terms indicated on the invoice or stated by contract. Invoices and account balances in arrears of stated terms may result in The Jackson Laboratory pursuing collection activities including but not limited to outside agencies and court filings.
The Jackson Laboratory has rigorous genetic quality control and mutant gene genotyping programs to ensure the genetic background of JAX® Mice strains as well as the genotypes of strains with identified molecular mutations. JAX® Mice strains are only made available to researchers after meeting our standards. However, the phenotype of each strain may not be fully characterized and/or captured in the strain data sheets. Therefore, we cannot guarantee a strain's phenotype will meet all expectations. To ensure that JAX® Mice will meet the needs of individual research projects or when requesting a strain that is new to your research, we suggest ordering and performing tests on a small number of mice to determine suitability for your particular project. We do not guarantee breeding performance and therefore suggest that investigators order more than one breeding pair to avoid delays in their research.
What information were you hoping to find through your search?
How easy was it to find what you were looking for?
We may wish to follow up with you. Enter your email if you are happy for us to connect and reachout to you with more questions.
Please Enter a Valid Email Address
Thank you for sharing your feedback! We are working on improving the JAX Mice search. Come back soon for exciting changes.